GHAZALEH ESKANDARI to Middle Aged
This is a "connection" page, showing publications GHAZALEH ESKANDARI has written about Middle Aged.
Connection Strength
0.025
-
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors. Clin Cancer Res. 2020 03 15; 26(6):1237-1246.
Score: 0.011
-
Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial. Neuroimmunomodulation. 2014; 21(6):291-6.
Score: 0.007
-
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial. Nutr Neurosci. 2014 Jan; 17(1):16-20.
Score: 0.007